Last $118.47 USD
Change Today -1.84 / -1.53%
Volume 6.4M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
NASDAQ GM
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas O. Daniel M.D.

President of Research & Early Development and Executive Vice President, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 27 board members in 2 different organizations across 6 different industries.

See Board Relationships
60$7,239,756
As of Fiscal Year 2013

Background*

Dr. Thomas O. Daniel, M.D., has been the President of Research & Early development of Celgene Corporation since December 2006 and also served as its Executive Vice President since February 15, 2012. Dr. Daniel has more than two decades of medical and pharmaceutical research experience and served as the Chief Scientific Officer at Ambrx Inc. since September 2003. He served as the Vice President of Research at Amgen Inc., where he served as Research Site Head of Amgen ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: 908-673-9001

Board Members Memberships*

Director
2012-2014
Former Director

Education*

MD
University of Texas Southwestern Medical Center - Dallas

Other Affiliations*

Annual Compensation*

Salary$645,833
Total Annual Compensation$645,833

Stock Options*

Restricted Stock Awards$1,059,360
All Other Compensation$100,434
Exercised Options76,364
Exercised Options Value$5,374,783
Exercisable Options94,278
Unexercisable Options107,458
Total Value of Options$5,374,783
Total Number of Options278,100

Total Compensation*

Total Annual Cash Compensation$3,911,273
Total Short Term Compensation$645,833
Other Long Term Compensation$1,159,794
Total Calculated Compensation$7,239,756
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $118.47 USD -1.84

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥170.0M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.